PEACEOFMND: Physical Exercise And Cognitive Engagement Outcomes For Mild Neurocognitive Disorder
Purpose
Over the two weeks of the PEACEOFMND study training, participants will engage daily in individual memory compensation training as well as group supportive therapy.
In addition, participants will be randomly assigned to 1 of 3 program components:
- Yoga
- Computer brain fitness
- Wellness education
These sessions are delivered by a caring, multidisciplinary team including psychologists, education specialists, social workers, cognitive interventionists and exercise specialists.
Participants will continue to engage at home in either yoga, computer brain fitness, or wellness techniques for six months after the initial 2-week program. Participants will visit UF in Gainesville to complete an MRI and cognitive measures before the program and six months later to look at the impact of these interventions on the brain, thinking skills, and well-being.
Eligibility
- Be diagnosed with amnestic MCI or Mild Neurocognitive Disorder, as confirmed by our criteria
- Be at least 50 years of age
- Have no MRI contraindications
- Have a “care-partner” that is willing to participate in the full program (such as a spouse, child or a good friend)
- The care-partner must be: at least 21 years of age and have no cognitive impairment, as confirmed by our criteria
For questions about study procedures or eligibility criteria, please contact Taylor Lambertus:
- tlambertus@phhp.ufl.edu
- (352) 294-8674
Study Information Flyer
Age
Gender
Monetary compensation
Can be done from home
Keywords
Neurology, Alzheimer's Disease and Other Cognitive Disorders Movement Disorders, Alzheimer's Disease Other Cognitive Memory DisordersPrincipal Investigator
Glenn Smith, PhDDepartment
Contact Information
Begin a new search for other research studies
Studies listed on this site have been approved by a UF Institutional Review Board (IRB), which works to ensure the welfare and rights of research participants as required by federal regulations. Study listings are provided by the UF Clinical and Translational Science Institute in collaboration with UF research teams and the UF IRBs.